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To the Editor: Donor organs for
transplantation are in extremely short
supply. The increased number of
patients with advanced liver disease
requiring transplantation has resulted
in the expansion of selection criteria
for potential donors. Previously unac-
ceptable or marginally acceptable
donors, such as those who die from
bacterial meningitis, are now donor
candidates (1).
Several case reports and small, ret-
rospective studies have shown that,
with appropriate antimicrobial drug
treatment, transplant recipients of
organs from donors with bacterial
meningitis do not have increased risk
for infection (2,3) or reduced graft
survival (3). However, endotoxemia
in liver transplant recipients has been
associated with graft failure and a
high mortality rate (4,5), and in gram-
negative bacterial infections, the
physiologic effects of endotoxin may
persist after adequate antimicrobial
drug treatment. We report a case of
liver transplantation in which the
donor had brain death from meningo-
coccal meningitis. This unique case
provided an opportunity to study the
serologic responses and clinical
course of an organ recipient after liver
transplantation from a donor who had
died of Neisseria meningitidis infec-
tion. Our observations suggest that
biologically relevant levels of anti-
gens, including endotoxin, may have
been transferred to the recipient.  
A 57-year-old woman with pro-
gressive sclerosing cholangitis and
cryptogenic cirrhosis received a liver
transplant from a previously healthy
18-year-old man who died of
serogroup C N. meningitidis meningi-
tis. He had received antimicrobial
drug therapy with ceftriaxone and
ampicillin for 5 days before brain
death was determined; cultures were
negative, and the mildly elevated liver
function tests, recorded on admission,
had resolved, and no evidence of
hepatic impairment was shown. 
The transplantation surgery was
prolonged (17 h) and technically diffi-
cult, requiring intraoperative blood
products (≈25 U), prolonged postop-
erative mechanical ventilation, blood
pressure support, and renal hemofil-
tration. Pathologic examination of the
recipient’s explanted liver showed
secondary biliary cirrhosis. The recip-
ient was given ceftriaxone before and
after transplantation for 7 days.
During postoperative week 4, she was
also treated for Pseudomonas aerugi-
nosa nosocomial pneumonia and
pleural effusion caused by
Enterococcus. She was extubated 3
weeks after transplantation and dis-
charged 5 weeks after transplantation.
No evidence of clinical infection with
N. meningitidis was identified.
Pathologic examination of the
explanted donor liver demonstrated
focal acute subcapsular necrosis, large
droplet fat accumulation, and mild
chronic portal inflammation. The N.
meningitidis isolated from the blood
and cerebrospinal fluid of the donor
was serogroup C by immunoprecipi-
tation, and the lipooligosaccharide
(LOS) immunotypes (determined by
Brenda Brandt, Walter Reed Army
Institute of Research, Washington,
DC.) were L2, L3, L7, and L9.
Banked serum specimens, obtained
from the recipient before the operation
and every week for 5 weeks after the
operation, were assayed for presence
of antibodies to N. meningitidis.
Elevated levels of immunoglobulin
(Ig) G antibodies (11.2 µg/mL at week
2; 22.5 µg/mL at week 4) (6) to the
group C meningococcal polysaccha-
ride capsule were detected in recipient
serum (Figure, panel A). Levels of
IgM antibodies to LOS L9 rose
sharply and peaked in the sample
taken 2 weeks after the operation
(Figure, panel B). Levels of IgM anti-
bodies to L3 also rose slightly between
weeks 2 and 4. IgG antibodies to the 4
LOS types and antibodies to outer
membrane vesicles were elevated in
the first week postoperation and then
declined (data not shown) and may
reflect antibodies present from intra-
operative blood products. Anti-
polysaccharide antibodies to Strepto-
coccus pneumoniae serotypes 14 and
23 and N. meningitidis serogroup A
also rose between weeks 2 and 4 post-
transplantation but were not above
values expected in normal adult sera at
any time. Bactericidal assays against
the infecting strain could not be per-
formed because of endogenous killing
that was not complement mediated
and was presumed to be caused by the
presence of antimicrobial drugs in the
serum samples.
The rise in IgM antibodies to LOS
L9 and IgG antibodies to group C
polysaccharide is consistent with a
response to exposure to Neisseria anti-
gens at the time of transplantation.
With effective antimicrobial drug
treatment, the recipient has little risk
for bacteremia after transplantation of
organs from donors dying of N. menin-
gitidis infection (3). However, bacteri-
al antigens, endotoxin, and cytokines
could potentially be sequestered in a
donor liver, especially when organ
transplantation occurs within days of
the bacteremic episode. Despite appro-
priate antimicrobial drug treatment of
the donor and recipient, and the
absence of any evidence of active
infection of the recipient, these data
suggest that proinflammatory endotox-
in and capsular polysaccharide from N.
meningitidis  were transplanted with
the donor liver. Although we cannot
definitively associate these findings
with the organ recipient’s difficult
intra- and postoperative course, this
case raises the question of the role of
proinflammatory responses to trans-
planted endotoxin in postoperative
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condition and graft dysfunction in this
critically ill population (9,10).
Prospective studies identifying and
quantifying endotoxin in the trans-
planted liver itself and in the recipient
may be valuable in assessing the
meaning of this finding. An assess-
ment of endotoxin transfer will assist
in further defining the risks associated
with organ transplantation from
donors with N. meningitidis infections
and may lead to the consideration of
additional interventions to mediate
the effects of endotoxin exposure. 
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Surveillance of
Human Calicivirus
in Spain 
To the Editor: Human calicivirus-
es (HuCVs) are an important cause of
acute viral gastroenteritis in young
children worldwide (1,2). In Spain,
norovirus infections are not subject to
specific surveillance; few data exist
about sporadic cases (3,4) and none
about outbreaks across the country.
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Figure. Pre-and posttransplantation serum antibodies as measured by enzyme-linked immunosorbent assay (ELISA). A) Immunoglobulin
(Ig) G antibodies to Neisseria meningitidis serogroup C capsular polysaccharide (CPS) determined as described by Arakere and Frasch
(7) with minor modifications. Samples were run in duplicate at 8 serial dilutions, and antibody concentrations were calculated relative to
the standard reference serum lot CDC 1992 (courtesy of G. Carlone, Centers for Disease Control and Prevention, Atlanta, GA). B) IgM
antibodies to N. meningitidis lipooligosaccharide (LOS) immunotypes (L2, L3, L7, L9). ELISA to detect antibodies to LOS immunotypes
L2, L3, L7, or L9 was performed as described (8), with minor modifications, by using goat antihuman IgG (g-specific, Kirkegaard & Perry,
Gaithersburg, MD, USA) or goat antihuman IgM (m-specific, Sigma, St. Louis, MO, USA) conjugated to alkaline phosphatase. Samples
were run in duplicate at 4 serial dilutions. OD, optical density.